| Product NDC: | 60505-2870 |
| Proprietary Name: | Ropinirole |
| Non Proprietary Name: | Ropinirole |
| Active Ingredient(s): | 4 mg/1 & nbsp; Ropinirole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-2870 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079165 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130329 |
| Package NDC: | 60505-2870-7 |
| Package Description: | 14000 TABLET, FILM COATED in 1 BOTTLE (60505-2870-7) |
| NDC Code | 60505-2870-7 |
| Proprietary Name | Ropinirole |
| Package Description | 14000 TABLET, FILM COATED in 1 BOTTLE (60505-2870-7) |
| Product NDC | 60505-2870 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ropinirole |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130329 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | ROPINIROLE HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |